Pulse
NIFTY 5024,980.40+0.35%
SENSEX81,720.10+0.28%
NIFTY SHARIAH 254,850.15+0.42%
GOLD 24K (10g)₹75,420+0.38%
SILVER (1kg)₹88,400-0.12%
ACTIVE IPOS8 Open+38% GMP
TCS₹4,124.50+1.18%
INFY₹1,892.40+1.22%
USD/INR₹83.92-0.04%
NIFTY 5024,980.40+0.35%
SENSEX81,720.10+0.28%
NIFTY SHARIAH 254,850.15+0.42%
GOLD 24K (10g)₹75,420+0.38%
SILVER (1kg)₹88,400-0.12%
ACTIVE IPOS8 Open+38% GMP
TCS₹4,124.50+1.18%
INFY₹1,892.40+1.22%
USD/INR₹83.92-0.04%
GEM AROMATICS LIMITED

GEM AROMATICS LIMITED

NSE: GEMAROMA
ChemicalsBasic MaterialsSMALL CAPMCap ₹775.7 Cr
₹148.50₹2.72 (+1.87%)

Market Closed • NSE

Market cap₹775.7 Cr
Enterprise value₹905.2 Cr
P/B1.72
EPS TTM₹-2.45
ROCE3.43%
D/E0.34
Dividend yield0.00%
Face value₹2.00
52W high₹249.00
52W low₹133.00
Price chart(1Y)
1Y Return:-9.22% (₹15.08)
H: ₹228L: ₹143.5
1W+2.36%
1M-2.24%
3M-19.68%
6M-14.51%
1Y-35.59%
Today at a glance

Day range

₹144.45₹149.60

52 week range

₹133.00₹249.00
Volume56.0K0.84x 20D avg
Free float50.00%-15.60% volume

GEM AROMATICS LIMITED closed at INR148.50 (+1.87%) on volume 0.84x its 20-day average, trading 40.36% below its 52-week high.

Technical analysis
RSI (14)41.3Neutral (30–70)
MACDBULLISHBullish (Above signal)
ATR (14)₹6.28High
SMA 20₹152.21BEARISH
SMA 50₹162.25BEARISH
SMA 100₹171.25BEARISH
SMA 200₹170.45BEARISH
CPR bottom₹147.12
Pivot₹146.67
CPR top₹146.22
What changed recently?

2026-Q2

Q2 FY2026 Financial Results

PAT moved -879.2% QoQ

Shariah audit
Methodology: AAOIFI Shariah Standard No. 21
PASS4/4 criteria
Shariah Compliant
CriteriaNumeratorDenominatorValueThresholdStatus
Interest-bearing debt ratio₹151.8 Cr₹775.7 Cr19.57%≤ 33%PASS
Non-halal income ratio–₹366.5 Cr0.00%≤ 5%PASS
Illiquid assets ratio₹633.7 Cr₹641.9 Cr98.73%≥ 20%PASS
Receivables ratio–₹641.9 Cr—≤ 49%PASS
Valuation & sector context
MetricCompanySector
P/E—21.90
Forward P/E——
P/B1.722.20
EV/EBITDA—18.00
PEG—1.00
Earnings yield—4.60
Growth & profitability
RevenuePAT
FY24PAT margin 11.10%
FY25PAT margin 10.50%
FY26PAT margin 0.40%

Revenue and PAT bars use independent scales to make their year-on-year direction readable.

Revenue CAGR 3Y-10.10%
Revenue CAGR 5Y-4.10%
PAT CAGR 3Y-70.00%
PAT CAGR 5Y-50.90%
Operating margin-5.89%
Net margin-3.82%
Financial health & cash flow
Net debt₹143.7 CrModerate
Interest coverage1.40xEBIT / interest
CFO / PAT0.62x3Y average
Net debt / EBITDA—Leverage
Operating cash flow₹29.6 Cr
Capital expenditure–
Free cash flow₹-6550.6 Lakh
Financial statements

Complete reported financial history · Values use the company's reporting currency

Hover over the chart for exact reported values. Percentage lines use the right-hand axis.

Fundamental scorecard
Overall60/100
Valuation50/100
Profitability50/100
Financial health80/100

A 0–100 quantitative summary of reported fundamentals. Use the underlying financials and risks for context; the score is not a buy or sell recommendation.

Strengths, risks & investment thesis

Strengths

Low Debt Profile: Debt-to-Equity is comfortable at 0.34x

Risks

Tight Debt Servicing: Interest coverage ratio is under 2.0x

Bull case

Market Leadership: Established operational scale in Chemicals.

Bear case

Macro Headwinds: Fluctuations in interest rates and sector-specific policy shifts could compress multiples.

Flip condition

Sustained quarterly EBITDA margin expansion above 20% would trigger an upgrade.

Shareholding pattern
Quarterly ownership historyLatest valid period · December 2025

Ownership distribution

Dec 2025Latest holding

Category trends

Hover over a period for exact holdings

60%40%20%0%Sept 2025Dec 2025
5.56%Institutional holding
37.00%Public holding
2Periods available
0.00%Promoter pledged
60.19KShareholders
Delivery participation

Traded volume and delivery percentage across the latest 20 sessions

Average delivery (20D)57.38%+1.89% latest vs average
Highest delivery70.46%on 28 Sept
Average volume (20D)66.4KTrading-session average
Conviction trendStrengthening+1.89% latest reading
Traded volumeDelivery %
Peer comparison

Compare valuation, latest quarterly performance and year-on-year growth

8 companies
Company nameMarket cap ₹ CrP/E ratioDividend yield %Quarterly sales ₹ CrProfit after tax ₹ CrSales growth %Profit growth %
UltraTech Cement Limited
UltraTech Cement LimitedULTRACEMCO
Open analysis
₹3.21L37.592.21%₹25,799.47₹2,982.76+11.86%+20.17%
JSW Steel Limited
JSW Steel LimitedJSWSTEEL
Open analysis
₹2.97L12.050.59%₹47,364.00₹4,651.00+11.55%+112.96%
Hindustan Zinc Limited
Hindustan Zinc LimitedHINDZINC
Open analysis
₹2.28L13.372.07%₹13,687.00₹5,425.00+77.22%+146.14%
Asian Paints Limited
Asian Paints LimitedASIANPAINT
Open analysis
₹2.24L46.941.17%₹10,541.94₹1,539.25+17.94%+39.96%
Tata Steel Limited
Tata Steel LimitedTATASTEEL
Open analysis
₹2.19L19.832.27%₹60,794.00₹2,385.00+14.32%+18.83%
Hindalco Industries Limited
Hindalco Industries LimitedHINDALCO
Open analysis
₹2.02L12.320.56%₹84,825.00₹7,013.00+32.06%+75.15%
Grasim Industries Limited
Grasim Industries LimitedGRASIM
Open analysis
₹1.98L34.820.35%₹11,794.71₹246.65-70.60%-82.61%
Solar Industries India Limited
Solar Industries India LimitedSOLARINDS
Open analysis
₹1.81L90.930.06%₹3,668.00₹666.00+70.29%+88.67%
About GEM AROMATICS LIMITED
GEM AROMATICS LIMITED

Incorporated in October 1997, Gem Aromatics Limited manufactures speciality ingredients, including essential oils, aroma chemicals, and Value-Added Derivatives in India.[1]

IndiaBasic Materials

Questions investors ask
Is GEM AROMATICS LIMITED Shariah compliant?

GEM AROMATICS LIMITED is currently screened as Shariah Compliant under AAOIFI Shariah Standard No. 21. Business activities align with Shariah permissible sectors. Debt to Market Cap (19.57%) complies with AAOIFI threshold (≤ 33%).

What is GEM AROMATICS LIMITED's current valuation relative to peers?

GEM AROMATICS LIMITED trades at a P/E of N/A compared to the sector median of 21.9x, and a Price-to-Book of 1.7x.

Is the company financially healthy?

The company has a Debt-to-Equity ratio of 0.34x. Interest coverage is 1.4x.

What are the historical revenue and profit growth rates?

Over the past 5 years, revenue compounded at -4.1% while net profit growth averaged -50.9%.

Market data is informational and may be delayed. Shariah screening follows the displayed methodology. This is not investment advice.

Market data may be delayed. Quote date: 2026-10-16. Financial figures relate to their stated reporting periods. This information is for research and is not a recommendation to buy or sell.